Cargando…
Efficacy and safety of Shen-Song-Yang-Xin capsule for treating arrhythmia in the elderly patients with coronary heart disease: Protocol for a systematic review and meta-analysis
BACKGROUND: Coronary heart disease (CHD) is a major cause of mortality worldwide. Shen-Song-Yang-Xin capsule (SSYXC) has received extensive attention as an alternative therapy in improving myocardial ischemia and hypoxia effectively. In addition, there has been no systematic review or meta-analysis...
Autores principales: | Zeng, Zhicong, Zhuang, ZhenJie, He, YingXian, Yang, ZhaoJun, Song, Yinzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320059/ https://www.ncbi.nlm.nih.gov/pubmed/30572466 http://dx.doi.org/10.1097/MD.0000000000013599 |
Ejemplares similares
-
Effect of Shen Song Yang Xin Capsule on Myocardial Electrophysiology of Acute Atrial Fibrillation in Canine Model
por: Zhang, Kai, et al.
Publicado: (2017) -
Efficacy and safety of ShenSongYangXin Capsule combined with antiarrhythmic drugs for atrial fibrillation: A protocol for systematic review and network meta-analysis
por: Shi, Shuqing, et al.
Publicado: (2020) -
Identification of Proteins Implicated in the Increased Heart Rate in ShenSongYangXin-Treated Bradycardia Rabbits by iTRAQ-Based Quantitative Proteomics
por: Liu, Zhouying, et al.
Publicado: (2015) -
Shen Song Yang Xin Capsule Combined with Antiarrhythmic Drugs, a New Integrative Medicine Therapy, for the Treatment of Frequent Premature Ventricular Contractions (FPVC): A Meta-Analysis of Randomized Controlled Trials
por: Wang, Jie, et al.
Publicado: (2014) -
Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
por: Liu, Miaomiao, et al.
Publicado: (2020)